Clarkston Financial Corporation Reports 2014 Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Clarkston Financial Corporation Reports 2014 Results

CLARKSTON, Mich., Feb. 10, 2015 (GLOBE NEWSWIRE) -- Clarkston Financial Corporation ("Corporation") (OTCBB: CKFC ), the holding company for Clarkston State Bank ("Bank"), today reported net income of $926,000 or $0.29 per share for the three months ended December 31, 2014, compared to net income of $5,016,000 or $1.55 per share for the three months ended December 31, 2013. For the twelve months ended December 31, 2014, the corporation reported net income of $1,736,000 or $0.59 per share compared to a net income of $5,502,000 or $1.70 per share for the same period in 2013. The decrease in earnings year over year is directly attributable to the tax effects of reversing the valuation allowance against the deferred tax asset made in 2013 and 2014. Pretax net income for the twelve months ended December 31, 2014 was $1,078,000 compared to $945,000 for December 31, 2013. This represents a year over year increase of $133,000 or 14.07% in pretax income for the Corporation.

J. Grant Smith, CEO, said, "The Bank posted outstanding financial results in 2014. We had great success with the rollout of additional electronic banking products, increased our loan portfolio and continued the expansion of our strong core deposit base. In December 2014, the Board of Directors made a decision to close two of our retail branches to reflect the changing behavior of our customers and the potential growth within the marketplace with an emphasis on electronic delivery systems. Our two full service retail branches combined with the latest electronic delivery systems will further complement our suite of products and give our customers more electronic tools to interface with our Bank. The market continues to evolve as it relates to smart phones, tablets etc. and we are adapting our business model to this paradigm shift. We are very proud of our team and we look forward to further expanding our market share in 2015."

Operating Results

The Corporation's net interest income increased to $1,353,000 for the quarter ended December 31, 2014 compared to $1,320,000 for the same period ended December 31, 2013. This represents a 2.50% increase over the prior year. The net interest margin of the Bank experienced compression due to stiffer loan competition, ending at 4.50% for the quarter ended December 31, 2014, down from 4.87% for the quarter ended December 31, 2013. However, the Bank's net interest margin continues to exceed peer levels.

Noninterest income had a decrease in the fourth quarter 2014, increased due to the write down of one of the Bank's two remaining other real estate owned properties reflected in 2013. The quarter ended at $203,000 compared to $92,000 for the quarter ended December 31, 2013, an increase of $111,000 or 120.65%. Noninterest expense continued to decline year over year, ending the fourth quarter 2014 at $1,288,000 compared to $1,423,000 for the same period ended December 31, 2013, a decrease of $135,000 or 9.49%. The decrease represents a decline in the expense related to troubled loans among other operating expenses.

Balance Sheet

Total assets at December 31, 2014 were $144,379,000 compared to $128,256,000 at December 31, 2013, an increase of $16,123,000 or 12.57%.

Total loans increased $9,792,000 from $103,015,000 at December 31, 2013 to $112,807,000 at December 31, 2014, an increase of 9.51%. Total deposits increased $14,124,000 or 1.27%, ending at $125,368,000 for December 31, 2014, up from $111,244,000 at December 31, 2013. Noninterest bearing demand deposits increased $11,926,000 from December 2013 to December 2014, reflecting an increase of 29.09%.

Total stockholders' equity increased from $10,974,000 at December 31, 2013 to $12,889,000 at December 31, 2014, an increase of $1,915,000 or 17.45%. This increase is due to the net income in 2014, mainly driven by the recapture of the remaining $1,000,000 in previously disallowed deferred tax asset in 2014. There is no longer any valuation allowance against the deferred tax asset.

Asset Quality

Total non-performing loans decreased to $144,000 at December 31, 2014 compared to $279,000 from the same period 2013, a decrease of $135,000, or 48.39%. The allowance for loan loss decreased to 1.63% of total loans as of December 31, 2014, compared to 1.74% for the same period 2013. Management continually monitors the allowance for loan loss to determine its adequacy.

Clarkston State Bank opened in January 1999 and operates four branches in Clarkston, Waterford, and Independence Township, Michigan.

Safe Harbor. This news release contains comments or information that constitute forward-looking statements within the context of the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve significant risks and uncertainties. Actual results may differ materially from the results discussed in the forward-looking statements. Factors that may cause such a difference include: changes in interest rates and interest-rate relationships; demand for products and services; the degree of competition by traditional and non-traditional competitors; changes in banking regulations; changes in tax laws; changes in prices, levies, and assessments; the impact of technological advances; governmental and regulatory policy changes; the outcomes of contingencies; trends in customer behavior and their ability to repay loans; and changes in the national and local economy. The Corporation assumes no responsibility to update forward-looking statements.

 
CLARKSTON FINANCIAL CORPORATION
CONSOLIDATED BALANCE SHEET
 
(Dollars, in thousands)    
  (unaudited)  
  12/31/2014 12/31/2013
Assets    
Cash and cash equivalents  $  11,908  $ 5,154
Securities – Available for sale 5,581 6,689
Federal Home Loan Bank stock, at cost 409 556
     
Loans 114,680 104,836
Allowance for possible loan losses (1,873) (1,821)
Net loans 112,807 103,015
     
Banking premises and equipment 4,809 4,814
Deferred tax asset 6,793 6,115
Other real estate owned 1,396 1,396
Accrued interest receivable and other assets 676 517
Total assets  $ 144,379  $ 128,256
Liabilities and Stockholders' Equity (Deficit)    
Liabilities    
Deposits    
Noninterest-bearing demand deposits 52,919 40,993
Interest-bearing 72,449 70,251
Total deposits 125,368 111,244
     
Other Liabilities    
Other borrowings 5,625 5,300
Accrued interest payable and other liabilities 497 738
Total liabilities 131,490 117,282
     
Stockholders' Equity    
Common stock 11,917 11,909
Paid-in capital 11,798 11,790
Restricted stock - Unearned compensation (24) (96)
Accumulated deficit (10,819) (12,555)
Accumulated other comprehensive income (loss) 17 (74)
Total stockholders' equity 12,889 10,974
     
Total liabilities and stockholders' equity  $ 144,379  $ 128,256
 
CLARKSTON FINANCIAL CORPORATION
CONSOLIDATED STATEMENT OF OPERATIONS
 
(Dollars, in thousands)  
   
  (unaudited) (unaudited)
  Three Months Ended Twelve Months Ended
  12/31/2014 12/31/2013 12/31/2014 12/31/2013
Interest Income        
Interest and fees on loans  $ 1,466  $ 1,425  $ 5,802  $ 5,502
Interest on investment securities: 35 39 141 113
Interest on federal funds sold 5 3 9 17
Total interest income 1,506 1,467 5,952 5,632
Interest Expense        
Deposits 53 61 210 294
Borrowings 100 86 347 342
Total interest expense 153 147 557 636
Net Interest Income 1,353 1,320 5,395 4,996
         
Provision for Possible Loan Losses   --  (470)  -- (410)
Net Interest Income after provision for possible loan losses 1,353 1,790 5,395 5,406
Noninterest Income        
Service fees on loan and deposit accounts 126 123 518 527
Gain on sale of securities  --  --  -- --
Loss on sale of other real estate owned -- (316) (3) (273)
Other 77 285 322 379
Total noninterest income 203 92 837 633
Noninterest Expense        
Salaries and employee benefits 758 754 2,893 2,591
Occupancy 152 143 584 598
Advertising 20 10 83 71
Outside processing 117 138 479 553
Professional fees 55 108 300 359
FDIC insurance 21 47 143 191
Defaulted loan expense 36 63 154 255
Other 129 160 518 476
Total noninterest expense 1,288 1,423 5,154 5,094
Income/(Loss) before income taxes 268 459 1,078 945
Income Tax Benefit   (658)  (4,557)  (658)  (4,557)
Net Income/(Loss)  $ 926  $ 5,016  $ 1,736  $ 5,502
 
CLARKSTON FINANCIAL CORPORATION
CONSOLIDATED FINANCIAL HIGHLIGHTS
 
(Dollars in thousands, except share and per share data)  
   
  Quarter Ended
   
  12/31/2014 9/30/2014 6/30/2014 3/31/2014 12/31/2013
MARKET DATA          
Book value per share  $ 3.97  $ 3.67  $ 3.58  $ 3.48  $ 3.38
Market value per share  $ 3.77  $ 4.35  $ 4.30  $ 4.60  $ 5.00
Earnings per share - basic & diluted  $ 0.29  $ 0.09  $  0.07  $ 0.09  $ 1.55
Period end common shares 3,246,156 3,246,156 3,246,156 3,246,156 3,242,596
           
PERFORMANCE RATIOS          
Return on average assets 2.59% 0.87% 0.70% 0.87% 15.94%
Return on average assets - CSB 2.47% 1.21% 1.11% 1.29% 13.36%
Return on average equity 30.80% 10.21% 8.13% 10.06% 330.03%
Return on average equity - CSB 21.05% 9.82% 8.92% 10.49% 123.70%
Net interest margin - CSB 4.50% 4.71% 4.93% 5.03% 4.87%
Efficiency ratio 82.80% 80.84% 84.64% 82.60% 100.78%
Texas Ratio 11.10% 11.40% 11.36% 12.54% 13.18%
           
CAPITAL & LIQUIDITY          
Tier 1 Leverage - CSB 8.78% 8.82% 9.30% 9.17% 8.98%
Tier 1 Risk Based Capital - CSB 9.68% 9.52% 9.82% 9.96% 9.71%
Total Risk Based Capital - CSB 10.93% 10.77% 11.08% 11.21% 10.96%
Loan to deposit ratio 91.47% 91.23% 94.72% 91.04% 94.24%
           
ASSET QUALITY          
Gross loan charge-offs  $   --  $   11  $  --   $   25  $     65
Net loan charge-offs (recoveries)  $   (20)  $ (12)  $ (20)  $    --  $   42
Allowance for loan and lease losses to total loans 1.63% 1.65% 1.67% 1.73% 1.74%
Nonperforming loans to total loans 0.13% 0.13% 0.13% 0.14% 0.27%
Nonperforming assets to total assets 1.07% 1.09% 1.15% 1.24% 1.31%
 
CLARKSTON FINANCIAL CORPORATION
LOAN INFORMATION
 
  (unaudited)  
CATEGORY 12/31/2014 12/31/2013
     
Commercial Loans  $ 13,776  $ 12,727
Real Estate Mortgage Loans:    
Commercial  91,497  82,874
1-4 Residential   5,086  6,017
Construction and other  4,136  3,017
Total mortgage loans on real estate  100,719  91,908
Consumer   185  201
Total Loans  114,680  104,836
Less: Allowance for loan losses  (1,873)  (1,821)
Net Loans  $ 112,807  $ 103,015
     
     
  (unaudited)  
ASSET QUALITY 12/31/2014 12/31/2013
     
Total nonaccrual loans  $ 144  $ 279
Total loans past due 90 days or more and still accruing  --   -- 
Total nonperforming loans  144  279
Other real estate owned   1,396  1,396
Total nonperforming assets  $ 1,540  $ 1,675

Media Contact: Clarkston Financial Corporation J. Grant Smith, CEO, 248-922-6945

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 250

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 254

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 353

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 155

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 143

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 313

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Total Voting Rights: A Crucial Overview

Updated Category News Views 192

Insights into Total Voting Rights and Capital Octopus AIM VCT plc is a company that regularly updates its shareholders regarding vital information, including total voting rights and capital structure. Current Share Capital Details As of the latest disclosure period, Octopus AIM VCT plc has an issued share capital comprising 223,655,160 Ordinary shares, each valued at 1...

Continue Reading
Understanding Market Sentiment for Bio-Techne's Stock

Updated Category News Views 130

Analyzing Bio-Techne's Market Position Bio-Techne (NYSE: TECH) has recently seen an increase in the short percent of float, now standing at 29.12% since its last report. This translates to approximately 5.08 million shares sold short, making up 3.68% of all available regular shares for trading. With the current trading volume, it would typically take about 2.66 days for...

Continue Reading
Innovative Developments in Wound Care by Kane Biotech Inc.

Updated Category News Views 120

Advancements in Wound Care from Kane Biotech Inc. WINNIPEG, Manitoba — Kane Biotech Inc. (TSX-V:KNE) is making headlines with groundbreaking clinical and scientific advancements in wound care. The company recently showcased its innovative data during the Innovations in Wound Healing Annual Meeting, an event dedicated to revolutionizing treatment in this critical field....

Continue Reading
Senior Helpers Achieves Recognition as a Leading Franchise

Updated Category News Views 178

Senior Helpers Achieves Recognition as a Leading Franchise Independent Survey Shows Franchise Owners Are Highly Satisfied with Senior Helpers' Support and Overall Performance Senior Helpers has recently been awarded the title of a Top Franchise for 2025 by Franchise Business Review (FBR). This year marks a significant milestone as it is FBR's 20th year of recognizing...

Continue Reading
Bearish Moves: What Big Players Think of Super Micro Computer

Updated Category News Views 232

Diving into Super Micro Computer's Options Landscape You gotta love this market, right? Sometimes it’s a real gut check, and right now, Super Micro Computer (NASDAQ:SMCI) is at the forefront of some, let’s say, interesting options activity. Financial giants are making bearish moves—like, big-time bearish. Our look into the options history for good ol' SMCI shook out...

Continue Reading